The following is a listing of recent U.S. Food and Drug Administration updates and activities:

• HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

• HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

• FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication

• Risk of False Positive Results with …

Sign Up for Free Trial

---

• Back
• MCN Blog